Horizon Discovery
Horizon Discovery: License Agreement agreed for Zinc Finger Nuclease Gene Editing Technology
Horizon Discovery
WSJ – Sigma Licenses CompoZr Zinc Finger Nuclease Technology
Horizon Discovery
Publication elucidates novel miR-34 tumor suppressor pathway
Horizon Discovery
Secures landmark deal with Hisun Pharmaceuticals A Cambridge UK pioneer in technology that will accelerate development of personalised medicines has secured a multi-million pound landmark deal with a Chinese pharmaceuticals giant….
Horizon Discovery
Parkwalk closes investment in Horizon Discovery for the University of Cambridge Enterprise Fund I Horizon’s basic science and translational research knowledge deployed in combination with best-in-class translational genomics platforms, products and services provides meaningful solutions to the challenges… Read More
